SCHEMBL2002805

SCHEMBL2002805

C/C=C/CCCCC(C)CCC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.37
TSHR P16473 1/20 0.36
ACE2 Q9BYF1 1/20 0.34
FFAR1 O14842 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33
PPARG P37231 2/20 0.33
GPR132 Q9UNW8 1/20 0.33
CNR1 P21554 1/20 0.32
GMNN O75496 1/20 0.31
USP2 O75604 1/20 0.31
CYP1A2 P05177 1/20 0.31
POLB P06746 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C9 P11712 1/20 0.31
ALOX15 P16050 1/20 0.31
APEX1 P27695 1/20 0.31
CYP2C19 P33261 1/20 0.31
RECQL P46063 1/20 0.31
BLM P54132 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2002806 1.00 LMNA (0.37) LMNATSHRACE2FFAR1FFAR4
SCHEMBL30368294 0.93 TSHR (0.37) LMNATSHRACE2
SCHEMBL2004353 0.93 TSHR (0.37) LMNATSHRACE2
SCHEMBL2004350 0.93 TSHR (0.37) LMNATSHRACE2
SCHEMBL31509314 0.89 ACE2 (0.46) LMNAACE2FFAR1FFAR4PPARG
SCHEMBL15544365 0.85 ACE2 (0.46) LMNAACE2FFAR1FFAR4PPARG
SCHEMBL15544367 0.85 ACE2 (0.46) LMNAACE2FFAR1FFAR4PPARG
SCHEMBL2007229 0.84 ACE2 (0.35) LMNAACE2PPARGCNR1GMNN
SCHEMBL2007228 0.84 ACE2 (0.35) LMNAACE2PPARGCNR1GMNN
SCHEMBL2010710 0.84 LMNA (0.33) LMNAFFAR1FFAR4PPARGGPR132

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120208959-A1 METHOD FOR PRODUCING AN AQUEOUS POLYMER DISPERSION BASF SE (DE) 2012-08-16 US disclosed
US-20120149840-A1 PROCESS FOR PRODUCING AN AQUEOUS POLYMER DISPERSION Univ. of Southern Mississippi Res. Foundation (US) 2012-06-14 US disclosed
US-7960477-B2 Polyamides with acrylate rubbers BASF SE (DE) 2011-06-14 US disclosed
US-7816441-B2 Dispersing assistant for emulsion and suspension polymerization BASF SE (DE) 2010-10-19 US disclosed
US-20100249325-A1 POLYMER POWDER WITH HIGH RUBBER CONTENT AND PRODUCTION THEREOF BASF SE (DE) 2010-09-30 US disclosed
US-20100234506-A1 AQUEOUS BINDER FOR FIBROUS OR GRANULAR SUBSTRATES BASF SE (DE) 2010-09-16 US disclosed
US-20100174025-A1 N-BA-ALKENE COPOLYMERS AS GRAFT BASE FOR ABS POLYMERS BASF SE (DE) 2010-07-08 US disclosed
US-20100152380-A1 PROCESS FOR PREPARING AN AQUEOUS POLYMER DISPERSION BASF SE (DE) 2010-06-17 US disclosed
US-20100093905-A1 AQUEOUS BINDER FOR GRANULAR AND/OR FIBROUS SUBSTRATES BASF SE (DE) 2010-04-15 US disclosed
US-20100069597-A1 FINE-PARTICLED POLYMER DISPERSIONS CONTAINING STARCH BASF SE (DE) 2010-03-18 US disclosed
US-20100048821-A1 POLYAMIDES WITH ACRYLATE RUBBERS BASF SE (DE) 2010-02-25 US disclosed
US-20100022708-A1 DISPERSING ASSISTANT FOR EMULSION AND SUSPENSION POLYMERIZATION BASF SE (DE) 2010-01-28 US disclosed
US-20090275681-A1 PROCESS FOR PREPARING AN AQUEOUS POLYMER DISPERSION BASF SE (DE) 2009-11-05 US disclosed
US-20080221267-A1 Process for Preparing an Aqueous Addition-Polymer Dispersion BASF AKTIENGESELLSCHAFT (DE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149840-A1 PROCESS FOR PRODUCING AN AQUEOUS POLYMER DISPERSION PUF60, PARG, ACMSD LMNA 2901/4885TSHR 4835/4885ACE2 4775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.